Introduction
Sixty years ago, a group of 13 visionary Swiss surgeons founded the Association of Osteosynthesis (AO) with the aim of improving fracture care [1] . At the time, most surgeons viewed osteosynthesis with suspicion because it was technically demanding and involved the risk of infection, so it was deemed too risky. The mainstay of fracture treatment consisted of conservative treatment. Fractures were treated with plaster casts and/or in traction so that patients were immobilized over many weeks. Typical sequelae consisted of muscle atrophy, stiff joints, loss of range of motion, and often subsequent invalidity [2] .
The founders of AO believed that fracture treatment could be improved by treating patients operatively. They developed treatment guidelines stipulating "restoration of the anatomy, stable fracture fixation, preservation of blood supply and early pain-free mobilization of limb and patient" [3] . According to AO's original bylaws, promotion of osteosynthesis should be achieved by studying issues involving bone fracture treatment, experimental research, and the exchange of practical and scientific experience related to osteosynthesis [3] .
The endeavor was successful. Today, osteosynthesis has become the standard treatment for most fractures in adults and AO has grown into a global non-profit organization with over 20 0 000 members [1] .
So far, no structured analysis has been performed to assess the impact of the actions defined in the original bylaws and their possible economic effects. On the occasion of the 60 th anniversary of AO, we initiated a collaboration with the Winterthur Institute of Health Economics (WIG) [4] , selected after an open call for the project, to evaluate AO's impact on the scientific community and education, on patient care from a health economic perspective, as well as on the MedTech business. The funding for the study was provided by AO as well as WIG.
Methods

Impact on the scientific community
To evaluate AO's impact on the scientific community, we analyzed the key book and journal publications brought forward by AO in the time since its foundation.
Citation frequencies of these publications in journals with high impact factors (IFs) were extracted from InCites, [5] which uses citation data from Web of Science [6] . Thresholds for the IFs were set depending on the field of research, i.e., for pre-clinical research only journals with an IF of >4 were considered, whereas for papers on clinical topics, the IF needed to be >3.
Journal publications were only included if they had been published before 2017 and were cited at least 6 times.
To determine "highly cited papers" and "hot papers", thresholds from InCites were applied. Papers are deemed "highly cited" if they receive a number of citations that brings them to the top 1% of papers in the respective research field published in the specified year. "Hot papers" are papers published in the past 2 years that received a number of citations in the most recent two-month period that places them in the top 0.1% of papers in the same field. Citation frequencies were analyzed separately for books, papers on pre-clinical topics, and papers on clinical topics.
Additionally, the development of the funding for the different areas of AO's research was analyzed.
Impact on education
AO's impact on educationwas evaluated by analyzing the evolution of the courses held by AO over time. The number of courses offered in different locations, the number of faculty members, as well as the number of participants registered was determined from AO's archives. An overview about AO's further educational activities was generated and its utilization was quantified.
Impact on patient care
The direct impact of AO on patient care is difficult to measure. However, since it was AO who disseminated the knowledge about how to successfully implement osteosynthesis (OS), the impact of OS is a suitable proxy for AO's impact on fracture care. Therefore, decision tree models were developed to calculate the differences in direct costs and productivity after treatment with OS compared to conservative treatment (CONS), assuming a hypothetical absence of OS, for the 3 index bones femur, tibia and radius. These 3 index bones were selected as they include frequent fracture locations of the upper and lower extremities and have specifically profited from AO innovations. Additionally, years of life gained (YLG) were calculated for femur and tibia fractures in analogy to the years of life lost (YLL) concept of the Global Burden of Disease Study [7] .
Input data were derived from Swiss real-world databases and extrapolated to 16 other high-income countries 1 (HICs). Costs were summed up for the time from AO's inception in 1958 up to 2017. Based on data availability, the analysis primarily considered the working population, i.e. patients < 65 years. For proximal femur fractures, an additional analysis considering patients � 70 years was performed because these fractures constitute a considerable and increasing disease burden in HICs [8] [9] [10] . These models are currently getting prepared for publication and a summary of the key results is presented herein.
Impact on the MedTech business
Using archival sources of the Synthes AG Chur on royalty payments by the various AO producers andfor the time from 1975 onwardscomplemented by historical sales figures provided by DePuy Synthes, we generated an overview about the development of AO's links to the MedTech business and estimated aggregate sales figures of products developed by AO since the very beginning of the AO.
Results
Impact on the scientific community
Developing the first edition of the "Manual of internal fixation" in 1963 [11] and later the "Comprehensive classification of fractures of long bones" [12] formed the bedrocks of AO's ongoing impact on the scientific community. The current editions and successors [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] of these publications are still cited at remarkable frequencies today. Between 2011 and 2016, the citation frequencies of the "Manual of Internal Fixation" [13] [14] [15] [16] 20, 22 ] and its predecessor [11] and successors [17, 18] were over 1800 times/ year and of the "Comprehensive Classification of Fractures of Long Bones" [12, 21] over 2000 times/year.
While the initial activities of AO focused on standardizing fracture treatment, soon pre-clinical research in cell and animal models and in material sciences was promoted. Fig. 1 depicts the citation frequencies of AO papers on pre-clinical topics between 2011 and 2016. One of these papers even met the criteria of a "hot paper" [30] .
Before long, research efforts were expanded to include clinical research. Driven by the change in mindset concerning evidence-based medicine, clinical research steadily gained importance. While in 2013, pre-clinical research received approximately twice the funds of clinical research, nowadays the funds for pre-clinical and clinical research are nearly equal. Today, AO invests approximately CHF 25 million for pre-clinical and clinical research annually. This had a substantial effect on citation frequencies of publications on clinical topics [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] ( Fig. 2 ).
Of note, AO's impact on the scientific community is not limited to publications. AO's research institute (ARI) focuses on pre-clinical research and development and publishes its own journal (European Cells & Materials, eCM), which also hosts a yearly conference and has held an IF � 4.0 in 8 of the 10 years since it was first classified in the Citation Index.
AO's impact on education
Davos courses
Shortly after AO was founded, the first instructional courses were held in Davos.
The "Davos Courses" are still AO's flagship educational activity. The aim of the courses is to impart knowledge theoretically and practically. Thus, an important part of the courses is the "hands-on" training, offering surgeons the opportunity to use the specific implants and instruments on sawbones or human specimens.
The first of these courses took place in December 1960 with 66 participants. Quickly, the courses gained popularity in the international communityalmost 90% of participants came from abroad. In 1969, the number of participants had already risen to 530 and this trend continued (Fig. 3) .
The number of course participants between 1960 and 2016 sums up to approximately 65 0 000. Worldwide courses Soon after having established the "Davos courses" in Switzerland, AO started to organize local AO courses throughout the world. Despite the "Davos courses" being the main educational activity, the worldwide courses played an important role in the dissemination of AO techniques and in fostering the worldwide AO network.
The first AO course outside Switzerland was held in Germany in 1965, followed by Yugoslavia in 1968, Canada in 1969, and Austria as well as the US in 1970. Based on the great success, courses usually continued to be held on a regular basis once they had been introduced into a country. Courses increased steadily so that by 1994, AO had held courses in 62 countries other than Switzerland. Fig. 4 shows the introduction of AO courses between 1960 and 1994 by country.
The number of worldwide AO courses increased continuously. After the millennium it exceeded 200 courses with 10 0 000 participants per year ( Fig. 5 ).
In 2016, AO held 727 courses with 45 0 000 participants worldwide, excluding the Davos courses.
In total, up to today, AO has held approximately 8 0 700 courses worldwide with 580 0 000 participants. Assuming an average course duration of 2.5 days, this translates into 20 0 000 teaching days, which were delivered by 2 0 500 volunteer faculty members [58] .
Other educational materials and activities
Nowadays, many educational materials are available online. On one hand, the AO Surgery Reference webpage, which contains detailed instructions for the complete surgical management process for all fractures of any given anatomical region, is a tool that is used by many surgeons worldwide. By early 2017, the reference webpage had about 40 0 000 returning visitors per month. In 2010, the corresponding mobile app was introduced, which has been downloaded between 6 0 000 and 8 0 000 times per month since 2013. In the first quarter of 2017, it was accessed by approximately 140 0 000 users per month.
On the other hand, videos, webinars and other online courses are available on a wide array of topics. The most recent development is a training program that focuses on research methodology for clinicians, the AOPEER (Program for Education and Excellence in Research). This program consists of both online resources and face-to-face training modules to provide the appropriate knowledge for surgeons to conduct high quality clinical research.
Fellowships
Another important way of training surgeons is the fellowship program, granting individual surgeons scholarships at AO hospitals, i.e., hospitals where experienced AO-affiliated surgeons are working. The fellows participate in all daily activities and observe or can even scrub-in on operations. This immersion allows them to learn the application of AO techniques including their correct indications directly from highly qualified experts, and thus guarantees for a learning experience that goes far beyond the lectures and the practical exercises during the courses. Modeling total cost differences between OS and CONS for the 3 index bones femur, tibia and radius demonstrated that in all these fractures, OS resulted in significant savings (Table 1) . This was highest in leg fractures of the working age population (femur: Swiss Francs [CHF] 131 0 000/patient, tibia: CHF 104 0 000/patient), primarily due to the significant indirect costs caused by prolonged absence from work inherent in CONS. Of note, even when only direct costs were considered, treating these fractures operatively would be less expensive than conservatively. In contrast, the direct costs for treating radius fractures operatively exceed those of CONS by CHF 4 0 500 per patient, still resulting in overall savings of CHF 13 0 700/patient.
Extrapolating these figures to 17 HIC (including Switzerland), the use of OS in femur, tibia and radius fractures alone led to savings of CHF 925 billion over the last 60 years.
The analysis of YLG was also clearly in favor of OS (Table 2 ). It was estimated that the introduction of OS to treat femoral and tibial fractures resulted in a total of 77.6 million YLG in the 17 HICs analyzed. Translating these figures into premature deaths avoided in the US alone in 2001 shows that treating femur and tibia fractures in patients < 65 years with OS saved 2 0 600 lives and treating proximal femur fractures with OS in patients � 70 years saved 126 0 000 lives.
Impact on the MedTech business
In addition to its educational and research activities, which enabled developing innovative yet reliable OS products, AO supervised production, marketing and sales of the latter and got in contact with potential manufacturers right in its beginnings. They established the non-profit company Synthes AG in Chur, which received all current and future intellectual property rights for instruments and implants developed by AO. In exchange to royalty payments, the Synthes AG granted exclusive production rights to Mathys and Straumann, who were the first to produce and sell AO equipment under the "Synthes" brand. Synthes brand sales, which comprised products manufactured and sold by various producers, increased exponentially over time and were not only a reliable source for funding AO's activities but also generated a large international business. From 1958-2017, overall Synthes brand sales amounted to approximately CHF 55 billion.
Discussion
Impact on the scientific community AO furthered a high number of publications with high citation frequencies. Figures show that the early books "The Comprehensive Classification of Fractures of Long Bones" [12] and "The Manual of Internal Fixation" [16] and two journal publications from the nineties and 2000s are still highly relevant today. Furthermore, numerous more recent pre-clinical and clinical papers have been and are cited at high frequencies.
Increasing numbers of papers have been published in high impact journals and many of them have received high citation rankings.
The main limitation of this analysis is that no figures are available to illustrate the proportional contribution of AO compared to the total of publications in a given research field. Notwithstanding, many AO papers are ranked as "highly cited" or even "hot paper". These proportional measures indicate the importance of AO's contributions relative to other papers in the research field.
Impact on education
The aim of AO courses has always been to disseminate knowledge along with practical skills in fracture treatment and has more recently been complemented with education in research methodology. As demonstrated by the increasing number of courses held in various parts of the world and rising numbers of participants, this was perceived well in the community. The evergrowing popularity of the AO courses suggests that they satisfied previously unmet needs. AO courses are nowadays CME accredited in many countries; in some countries, attendance of one or more AO courses is even compulsory for board certification of orthopedic surgeons [58] . Experts estimate that if AO were put together as a full-blown medical school, it would, at a minimum, equal a medium-sized institution [58] .
Additionally, AO's increased activities in low-and middleincome countries play an important role in providing advanced education in regions where appropriate medical training is a scarce resource.
Impact on patient care
In our impact evaluation we used the effect of the technology "osteosynthesis" as a proxy for AO's impact on patient care.
To assess cost savings, we used combined estimates (femur, tibia and radius fractures in the population age <65 years and proximal femur fractures in patients aged � 70). This showed that in 17 HICs alone, introduction of the technology OS resulted in a potential net benefit of 925 billion CHF and 77.6 million YLG over the last 60 years. Not many studies have evaluated the impact of medical innovations of a similar magnitude. One of these studies assessed the impact of antihypertensive drugs in the US by quantifying the number of premature deaths avoided [59] . The study estimated that treatment with antihypertensive drugs saved 86 0 000 lives in the population aged 30-79 years in 2001. We estimated for the same time frame, that OS in the US avoided 2 0 600 premature deaths in persons < 65 years and 126 0 000 premature deaths in persons � 70 years.
The main limitation of our approach is that the modeling is based on several assumptions and simplifications. However, appropriate measures including various sensitivity analyses were taken to test the robustness of our estimations. Overall, the underlying assumptions were rather conservative, e.g., we only included 3 index bones in 17 HICs and indirect costs of unpaid work were not considered. Thus, the overall impact of OS is likely to be even bigger. Additionally, the AO founders were not the first surgeons believing in the benefits of OS. Others such as Lambotte, Danis or Küntscher also propagated the idea of treating fractures with OS, even though their ideas and efforts did not gain a comparable spread. It seems possible that another organization may have formed and stepped into the breach to further develop and promote the technology. Nowadays, several large manufacturers provide OS products developed independently of AO or Synthes. It is impossible, however, to tell whether or how long it would have taken for OS to gain a comparable spread around the world without AO's efforts that comprised the exceptional combination of research, education and manufacturing.
Impact on MedTech business and synergistic effects
AO's involvement in the Synthes brand allowed the manufacturers to grow rapidly and generate a large international business. Synthes branded products alone, generated sales of approximately CHF 55 billion since AO's foundation. The combination of activities leading up to this was unique. High quality research formed the basis to develop successful surgical techniques, corresponding implants and instruments as well as training on how to use these in theory and practice.
Conclusion
In the 60 years since its inception, AO has grown from a small Swiss association comprising a handful of pioneer surgeons into a globally active foundation with over 20 0 000 members worldwide.
Our analysis shows that AO's impact on science, education, patient care, and finally the MedTech business was significant. This was only possible because AO addressed hitherto unmet needs by combining activities that mutually enriched and reinforced each other. In doing so, AO furthered the safe and effective use of OS, which led to a paradigm shift in fracture treatment and ultimately improved patient care all over the world. 
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